These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36846762)

  • 1. A strategy for addicting transgene-free bacteria to synthetic modified metabolites.
    Kato Y
    Front Microbiol; 2023; 14():1086094. PubMed ID: 36846762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recoded organisms engineered to depend on synthetic amino acids.
    Rovner AJ; Haimovich AD; Katz SR; Li Z; Grome MW; Gassaway BM; Amiram M; Patel JR; Gallagher RR; Rinehart J; Isaacs FJ
    Nature; 2015 Feb; 518(7537):89-93. PubMed ID: 25607356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications.
    Whitford CM; Dymek S; Kerkhoff D; März C; Schmidt O; Edich M; Droste J; Pucker B; Rückert C; Kalinowski J
    J Biol Eng; 2018; 12():13. PubMed ID: 30123321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances on transgene containment technologies].
    Zhang Q; Zhang JF; Fu WF; Zhang HJ; Yuan WJ
    Yi Chuan; 2011 May; 33(5):437-42. PubMed ID: 21586390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in synthetic biosafety.
    Simon AJ; Ellington AD
    F1000Res; 2016; 5():. PubMed ID: 27635235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect.
    Wegmann U; Carvalho AL; Stocks M; Carding SR
    Sci Rep; 2017 May; 7(1):2294. PubMed ID: 28536456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling the Implementation of Transgenic Microbes: Are We Ready for What Synthetic Biology Has to Offer?
    Stirling F; Silver PA
    Mol Cell; 2020 May; 78(4):614-623. PubMed ID: 32442504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmids as Tools for Containment.
    GarcíA JL; Díaz E
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-Sectional Survey of Biosafety Professionals Regarding Genetically Modified Insects.
    O'Brochta DA; Tonui WK; Dass B; James S
    Appl Biosaf; 2020 Mar; 25(1):19-27. PubMed ID: 32655328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the transgene containment level provided by chloroplast transformation.
    Ruf S; Karcher D; Bock R
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):6998-7002. PubMed ID: 17420459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating biological containment strategies for pollen-mediated gene flow.
    Hüsken A; Prescher S; Schiemann J
    Environ Biosafety Res; 2010; 9(2):67-73. PubMed ID: 21288462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Containment of Genetically Modified Bacillus subtilis.
    Hosseini S; Curilovs A; Cutting SM
    Appl Environ Microbiol; 2018 Feb; 84(3):. PubMed ID: 29150519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An engineered bacterium auxotrophic for an unnatural amino acid: a novel biological containment system.
    Kato Y
    PeerJ; 2015; 3():e1247. PubMed ID: 26401457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocontainment strategies for live lactic acid bacteria vaccine vectors.
    Lee P
    Bioeng Bugs; 2010; 1(1):75-7. PubMed ID: 21327129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of tissue differentiation influences the activation of a heat-inducible flower-specific system for genetic containment in poplar (Populus tremula L.).
    Hoenicka H; Lehnhardt D; Nunna S; Reinhardt R; Jeltsch A; Briones V; Fladung M
    Plant Cell Rep; 2016 Feb; 35(2):369-84. PubMed ID: 26521210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.
    Braat H; Rottiers P; Hommes DW; Huyghebaert N; Remaut E; Remon JP; van Deventer SJ; Neirynck S; Peppelenbosch MP; Steidler L
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):754-9. PubMed ID: 16716759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocontainment of genetically modified organisms by synthetic protein design.
    Mandell DJ; Lajoie MJ; Mee MT; Takeuchi R; Kuznetsov G; Norville JE; Gregg CJ; Stoddard BL; Church GM
    Nature; 2015 Feb; 518(7537):55-60. PubMed ID: 25607366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation biocontainment systems for engineered organisms.
    Lee JW; Chan CTY; Slomovic S; Collins JJ
    Nat Chem Biol; 2018 Jun; 14(6):530-537. PubMed ID: 29769737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A General Strategy for Engineering Noncanonical Amino Acid Dependent Bacterial Growth.
    Koh M; Yao A; Gleason PR; Mills JH; Schultz PG
    J Am Chem Soc; 2019 Oct; 141(41):16213-16216. PubMed ID: 31580059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.